Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.


MediMabBio is pleased to announce our poster presentation at the upcoming EACR2024 conference, where we will update our latest advancements in cancer therapy research.

Event: EACR2024 (10-13 June 2024, Rotterdam)
Presentation Title: Development of a Novel Anti-TIGIT IL-15 Fusion Antibody for Enhanced Anti-Tumour Therapy

Our research team will share valuable insights into the development of a novel anti-TIGIT IL-15 fusion antibody, which holds significant promise for enhancing anti-tumor therapies. This innovative approach highlights our commitment to pioneering advancements in cancer treatment.

We look forward to engaging with fellow researchers, industry experts, and partners at EACR2024, fostering collaborations and discussions that will drive the future of cancer research.

Stay tuned for more updates and detailed findings from the conference.